biologics-bone tissue

Spine Desk Reference

Spine Technology Awards

Pioneer Surgical
 
Simply Innovative by spineart
OsteoMed
OMTEC 2012
Customized Automated Messaging - PhoneTree
Pearl Diver
Photo creation by RRy Publications LLC Source: Bioventus LLC

Smith & Nephew’s Bold Spin Off
Robin Young • Mon, May 14th, 2012

 

Smith & Nephew’s deal with Essex Woodlands to spin off its clinical therapies business into a new company, called Bioventus, raises the specter of a well-capitalized, nimble and aggressive biologic/injectables challenge to the metal and plastic implant business. Is SNN trying to obsolete itself? Well, better them than someone else. Here’s what’s happening.

Source: Flexion Therapeutics, Inc.

Could This Be Orthopedics’ Future?
Robin Young • Thu, Mar 8th, 2012

 

One small Boston company may have the future of orthopedics in its grasp. What if steroid pain relief lasted months instead of weeks? What if the largest osteoarthritis pain relief signal ever seen was available for intra-articular injection? Well, get ready. They’re on the way.

Neuron in tissue culture. Source: Wikimedia Commons and Gerry Shaw

One Banker’s View of Orthopedics
Kelly O’Hara Dyer • Mon, Feb 20th, 2012

 

One Banker’s View of Orthopedics: "It’s my belief that the next wave of innovation in orthopedics is going to happen outside of big companies, where biologics technologies will be developed” So says one of the most active bankers in orthopedics – Chris Velis.

New York Stem Cell Summit 2012

New York Stem Cell Summit Preview
Robin Young • Tue, Jan 10th, 2012

 

Reflecting the dynamic nature of the industry, this year’s Stem Cell Summit has a record number of new presenters and one notable drop out—Geron. No question, adult stem cells are king of the hill for clinicians, but are embryonic stem cell therapies gone for good? The answer may surprise. Read on.

Inherit the Wind starring Spencer Tracy, Frederick March and Harry Morgan. Courtesy Wikimedia Commons

Carragee for the Prosecution
Robin Young • Mon, Dec 5th, 2011

 

In the recent issue of The Spine Journal, Eugene Carragee, M.D., writes more like prosecutor-in-chief than editor-in-chief as he resumes his attack on the use of rhBMP2 and its clinical investigators. The plaintiff’s bar is cheering. But NASS members are reeling. Who to believe? Read the details here.

Image created by RRY Publications, LLC. Source: MiMedx

Answer: Traction, a Screw and MiMedx
Robin Young • Tue, Oct 11th, 2011

 

Question: What are three terrific new technologies or companies in orthopedics? We see new product ideas and companies every week, but these three recent candidates stood out for their innovation and practicality. See if you agree.

Image creation by RRY Publications, LLC. Source: Wikimedia Commons

Five Stem Cell Companies in Orthopedics
Robin Young • Mon, Aug 22nd, 2011
1 Comment

 

Five companies, we think, stand out when it comes to non-allograft stem cells. These firms either have stem cell products on the market or are in the very advanced stages of bringing therapeutic stem cells to the rank and file orthopedic surgeon. Check it out.